EUVIMEDEUVIMED entdecken
Multizentrische Studie

SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period

Dimitra Dimopoulou, Despoina Sotiri, Dimitra Kousi, Garyfallia Loulou, Kalliopi Raptaki, Ariadni Neofytou, Foteini Dasoula, Maria Tampouratzi, Athina Koloi, Eirini Eleftheriou, Eleni Vergadi, Eleni Papadimitriou und 17 weitere

European Journal of Pediatrics · 2024

DOI: 10.1007/s00431-024-05486-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Dimitra Dimopoulou und 28 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens, 'P. and A. Kyriakou' Children's Hospital, Thivo…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Omicron variant is associated with increased transmissibility, but evidence about the impact of Omicron in seropositivity of children is limited. This study aims to evaluate SARS-CoV-2 seroprevalence in children during the different variants' subperiods. A prospective multicenter seroprevalence study was conducted in 7 University public hospitals in Greece from November 2021 to August 2022 (3 subperiods: November 2021-February 2022, March 2022-May 2022, June 2022-August 2022). Children from different age groups, admitted to the hospital or examined in outpatient clinics for reasons other than COVID-19 were enrolled. Neutralizing antibodies (Nabs), anti-Spike (anti-S) and anti-nucleocapsid (anti-N) SARS-CoV-2 IgG in serum were evaluated. A total of 2127 children (males:57,2%; median age:4,8years) were enrolled. Anti-N IgG seropositivity increased from 17,8% in the first sub-period to 40,7% in the second sub-period and then decreased in the third sub-period (36,7%). Anti-S IgG seropositivity appeared to have an increasing trend over the study period, starting from 34,8% and reaching 80,7%. Children aged 1-4 years old have significantly higher anti-N IgG titers compared to children aged 0-1 years old (p < 0,001). Infants have significantly lower anti-S IgG titers compared to all other age groups (p < 0,001). Immunocompromised children and infants have the lowest seropositivity for NAbs.Conclusions During the Omicron period, seropositivity significantly increased, as a result of higher transmissibility. Neonates and infants have lower antibody titers compared to other age groups, while young children aged 1-4 years old present higher antibody titers, suggesting that this age group may mount a higher antibody response. Continuous surveillance seroprevalence studies are needed in children, in order to identify the true extent of SARS-CoV-2 and guide the planning of adequate public health measures. WHAT IS KNOWN: • Seroprevalence surveys among children may be extremely useful, in order to properly monitor the immunity, either natural or acquired, through the quantification of IgG antibodies and to plan further immunization policies. • There are variations in the seroprevalence of COVID-19 between the different periods, according to the vaccination rates, the type of circulating variant and the transmissibility of the virus. • The Omicron variant is associated with increased transmissibility, but evidence about the impact of Omicron in seropositivity of children is limited. WHAT IS NEW: • In this large multicenter seroepidemiological study, SARS-CoV-2 seroprevalence rate in children is higher during the Omicron period in comparison to the previous pandemic waves, due to the high transmissibility of the virus and the increased rates of reinfection. • Neonates and infants have lower antibody titers compared to other age groups, while young children aged 1–4 years old present higher antibody titers, indicating that the children of this age group mount a higher antibody response. • This study provides essential information about immunity and the level of protection in the pediatric population, as neutralizing antibodies were evaluated, in addition to the anti-N and anti-S IgG antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antibodies, ViralHumansGreeceSeroepidemiologic StudiesChild, PreschoolMaleFemaleChildProspective StudiesInfantAdolescentImmunoglobulin GAntibodies, NeutralizingInfant, NewbornCOVID-19 Serological Testing

Stichwörter der Autor:innen

COVID-19ChildrenOmicronSARS-CoV-2SeroepidemiologySeroprevalenceVariants

Substanzen

Antibodies, ViralImmunoglobulin GAntibodies, Neutralizing

Autor:innen und Institutionen

  • Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens, 'P. and A. Kyriakou' Children's Hospital, Thivon and Leivadias, Athens, 30601, Greece.
  • Central Public Health Laboratory, Hellenic Centre for Diseases Control and Prevention, Athens, Greece.
  • Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, 15451, Greece.
  • School of Medicine, Department of Paediatrics, University General Hospital of Heraklion, University of Crete, Heraklion, Greece.
  • School of Health Sciences, Faculty of Medicine, Department of Paediatrics, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.
  • Department of Pediatrics, Venizeleion General Hospital, Heraklion, Greece.

Zitieren

APA

Dimopoulou, D., Sotiri, D., Kousi, D., Loulou, G., Raptaki, K., Neofytou, A., Dasoula, F., Tampouratzi, M., Koloi, A., Eleftheriou, E., Vergadi, E., Papadimitriou, E., Zorbadaki, I., Mavridi, A., Miliordos, K., Steletou, E., Strempela, M., Fragkou, P. C., Spoulou, V., …, & Tsolia, M. N. (2024). SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05486-7

Vancouver

Dimopoulou D, Sotiri D, Kousi D, Loulou G, Raptaki K, Neofytou A, et al. SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05486-7

BibTeX
@article{Dimopoulou2024,
  author = {Dimopoulou, Dimitra and Sotiri, Despoina and Kousi, Dimitra and Loulou, Garyfallia and Raptaki, Kalliopi and Neofytou, Ariadni and Dasoula, Foteini and Tampouratzi, Maria and Koloi, Athina and Eleftheriou, Eirini and Vergadi, Eleni and Papadimitriou, Eleni and Zorbadaki, Irini and Mavridi, Artemis and Miliordos, Konstantinos and Steletou, Evangelia and Strempela, Maria and Fragkou, Paraskevi C and Spoulou, Vassiliki and Michos, Athanasios and Gkentzi, Despoina and Papaevangelou, Vassiliki and Ladomenou, Fani and Grivea, Ioanna and Syrogiannopoulos, George and Galanakis, Emmanouil and Zaoutis, Theoklis and Tryfinopoulou, Kyriaki and Tsolia, Maria N},
  title = {SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period},
  journal = {European Journal of Pediatrics},
  year = {2024},
  doi = {10.1007/s00431-024-05486-7}
}
Kostenlos starten →